Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in Interest ReceivablesChange in Net LoansChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iBio (IBIO) Change in Net Loans (2024 - 2025)

iBio (IBIO) has disclosed Change in Net Loans for 2 consecutive years, with $46000.0 as the latest value for Q2 2025.

  • On a quarterly basis, Change in Net Loans changed N/A to $46000.0 in Q2 2025 year-over-year; TTM through Jun 2025 was $758000.0, a N/A change, with the full-year FY2025 number at $758000.0, changed N/A from a year prior.
  • Change in Net Loans was $46000.0 for Q2 2025 at iBio, up from -$1000.0 in the prior quarter.
  • In the past five years, Change in Net Loans ranged from a high of $713000.0 in Q3 2024 to a low of -$1000.0 in Q4 2024.